RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Berkley Heights, NJ 07922, NDC 51991-747-10.

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
March 26, 2025
Posted
April 9, 2025
Recall Number
D-0308-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
14,863 bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.

Distribution

Nationwide in the US

Lot / Code Info

Lot 240909C, Exp Date 03/31/2027

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls